Related Experiment Videos
3rd international symposium on genetic anticancer agents
Piotr J Wysocki1, Malgorzata Mackiewicz-Wysocka
1Department of Cancer Immunology, Chair of Oncology, USOMS, at GreatPoland Cancer Center, Garbary Street 15, 61-866 Poznan, Poland. pwysocki@plusnet.pl
Abstract:
The 3rd International Symposium on Genetic Anticancer Agents was an initiative of NDDO Research Foundation, which is an internationally operating organisation exclusively devoted to the research and development of new strategies for the treatment of cancer. The meeting focused on the preclinical and clinical development of various genetic agents for cancer treatment. Leading world experts came to Amsterdam to present recent results of their highly advanced research and to discuss novel approaches to cancer treatment. In addition to the scientific sessions, the organisers prepared an educational session devoted to the development process of a gene therapy product and to the design of clinical trials. The educational session aroused a great interest from the participants. The meeting highlights from different scientific sessions are presented.
Insights
The 3rd International Symposium on Genetic Anticancer Agents highlighted novel genetic strategies for cancer treatment. Experts discussed preclinical and clinical advancements in gene therapy and trial design.
Area of Science:
- Oncology
- Genetics
- Pharmacology
Background:
- The NDDO Research Foundation convened the 3rd International Symposium on Genetic Anticancer Agents.
- The symposium focused on the development of novel genetic agents for cancer therapy.
Framework:
- The event featured presentations by leading global experts in cancer research.
- Discussions centered on preclinical and clinical advancements in genetic anticancer agents.
Implementation:
- Scientific sessions showcased recent research findings and novel treatment approaches.
- An educational session addressed the gene therapy product development process and clinical trial design.
Implications:
- The symposium facilitated knowledge exchange on cutting-edge genetic anticancer strategies.
- It underscored the importance of interdisciplinary collaboration in advancing cancer treatment.